RENAL CYTOCHROME P450 EPOXYGENASE IN DIABETIC METABOLIC SYNDROME

$87,879G12FY2010RRNIH

Morehouse School Of Medicine, Atlanta GA

Investigators

Linked publications, trials & patents

Paper 39312480 Paper 38956413 Paper 37915580 Paper 37887242 Paper 37268696 Paper 37205467 Paper 36473396 Paper 36246576 Paper 35585291 Paper 35159951 Paper 31964750 Paper 31607207 Paper 31388084 Paper 31341634 Paper 30968433 Paper 30777016 Paper 30777008 Paper 30503337 Paper 30259980 Paper 30099039 Paper 30059666 Paper 29940798 Paper 29624896 Paper 29259391 Paper 29247541 Paper 29147885 Paper 28941766 Paper 28938399 Paper 28805677 Paper 28638788 Paper 28497076 Paper 28246585 Paper 28138846 Paper 28124024 Paper 28076321 Paper 27857867 Paper 27741577 Paper 27596278 Paper 27595130 Paper 27590851 Paper 27568798 Paper 27472371 Paper 27314810 Paper 27274952 Paper 27123541 Paper 27044659 Paper 27019796 Paper 26933040 Paper 26912237 Paper 26780313 Paper 26665166 Paper 26643403 Paper 26496733 Paper 26378239 Paper 26332568 Paper 26322843 Paper 26242911 Paper 26232609 Paper 26207312 Paper 25880399 Paper 25849723 Paper 25806020 Paper 25781554 Paper 25679011 Paper 25664332 Paper 25659774 Paper 25594072 Paper 25525571 Paper 25500576 Paper 25355949 Paper 25301939 Paper 25299690 Paper 25285241 Paper 25285238 Paper 25203735 Paper 25192910 Paper 25104354 Paper 25088353 Paper 25052506 Paper 24917673 Paper 24903552 Paper 24877741 Paper 24847103 Paper 24772448 Paper 24558093 Paper 24519934 Paper 24479147 Paper 24458158 Paper 24446297 Paper 24389259 Paper 24347342 Paper 24338332 Paper 24333669 Paper 24202338 Paper 24187132 Paper 24183943 Paper 24179307 Paper 24138116 Patent 8367350 Patent 7943139

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Specific Aims The overall goal of this project remains the same and is to elucidate the regulatory mechanism(s) and functional consequences of cytochorme P450 (CYP) epoxygenase metabolites (EETs) in the development and progression of vascular and renal dysfunction related to diabetic metabolic syndrome. Experiments performed over the project period have resulted in significant progress on the three Specific Aims. In addition, we have expanded our recent studies to determine glomerular epithelial injury in progressive diabetic nephropathy.

View original record on NIH RePORTER →